U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07678112) titled 'Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy' on June 18.
Brief Summary: This study aims to evaluate a new tool designed to help doctors decide whether it is safe to reduce medication in patients with rheumatoid arthritis (RA) who are in remission.
Rheumatoid arthritis is a chronic inflammatory disease that affects the joints, causing pain, stiffness, and reduced mobility. Many patients receive long-term treatment with biological drugs to control the disease. When the disease is well controlled (remission), doctors may gradually reduce the medication dose. However, deciding when and ...